188 related articles for article (PubMed ID: 30663140)
1. Determination of minimum inhibitory concentrations for silver sulfadiazine and other topical antimicrobial agents against strains of Pseudomonas aeruginosa isolated from canine otitis externa.
von Silva-Tarouca MSE; Wolf G; Mueller RS
Vet Dermatol; 2019 Apr; 30(2):145-e42. PubMed ID: 30663140
[TBL] [Abstract][Full Text] [Related]
2. Evaluating synergy between marbofloxacin and gentamicin in Pseudomonas aeruginosa strains isolated from dogs with otitis externa.
Jerzsele Á; Pásztiné-Gere E
Acta Microbiol Immunol Hung; 2015 Mar; 62(1):45-55. PubMed ID: 25823453
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimicrobial activity of topical otological antimicrobials and Tris-EDTA against resistant Staphylococcus pseudintermedius and Pseudomonas aeruginosa isolates from dogs.
Boyd M; Santoro D; Gram D
Vet Dermatol; 2019 Apr; 30(2):139-e40. PubMed ID: 30672043
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa.
Mekić S; Matanović K; Šeol B
Vet Rec; 2011 Jul; 169(5):125. PubMed ID: 21742683
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine.
Trott DJ; Moss SM; See AM; Rees R
Aust Vet J; 2007 Nov; 85(11):464-6. PubMed ID: 17970852
[No Abstract] [Full Text] [Related]
6. Identification and antimicrobial susceptibility patterns of bacteria causing otitis externa in dogs.
Zamankhan Malayeri H; Jamshidi S; Zahraei Salehi T
Vet Res Commun; 2010 Jun; 34(5):435-44. PubMed ID: 20526674
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa.
Martín Barrasa JL; Lupiola Gómez P; González Lama Z; Tejedor Junco MT
J Vet Med B Infect Dis Vet Public Health; 2000 Apr; 47(3):191-6. PubMed ID: 10829573
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections.
Teresa Tejedor M; Martín JL; Navia M; Freixes J; Vila J
Vet Microbiol; 2003 Jul; 94(4):295-301. PubMed ID: 12829383
[TBL] [Abstract][Full Text] [Related]
9. The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries.
Pietschmann S; Meyer M; Voget M; Cieslicki M
Vet Dermatol; 2013 Aug; 24(4):439-45, e96-7. PubMed ID: 23721182
[TBL] [Abstract][Full Text] [Related]
10. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa.
Chan WY; Khazandi M; Hickey EE; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2019 Apr; 30(2):133-e38. PubMed ID: 30548715
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance, integron carriage, and gyrA and gyrB mutations in Pseudomonas aeruginosa isolated from dogs with otitis externa and pyoderma in Brazil.
Arais LR; Barbosa AV; Carvalho CA; Cerqueira AM
Vet Dermatol; 2016 Apr; 27(2):113-7e31. PubMed ID: 26833540
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro.
Pye CC; Yu AA; Weese JS
Vet Dermatol; 2013 Aug; 24(4):446-9, e98-9. PubMed ID: 23738965
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial testing of selected fluoroquinolones against Pseudomonas aeruginosa isolated from canine otitis.
McKay L; Rose CD; Matousek JL; Schmeitzel LS; Gibson NM; Gaskin JM
J Am Anim Hosp Assoc; 2007; 43(6):307-12. PubMed ID: 17975212
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa susceptibility, antibiogram and clinical interpretation, and antimicrobial prescribing behaviors for dogs with otitis in the Midwestern United States.
KuKanich KS; Bagladi-Swanson M; KuKanich B
J Vet Pharmacol Ther; 2022 Sep; 45(5):440-449. PubMed ID: 35698441
[TBL] [Abstract][Full Text] [Related]
15. Comparison between clinical evaluations and laboratory findings and the impact of biofilm on antimicrobial susceptibility in vitro in canine otitis externa.
Luciani L; Stefanetti V; Rampacci E; Gobbi P; Valentini L; Capuozzo R; Passamonti F
Vet Dermatol; 2023 Dec; 34(6):586-596. PubMed ID: 37580811
[TBL] [Abstract][Full Text] [Related]
16. Biofilm production by pathogens associated with canine otitis externa, and the antibiofilm activity of ionophores and antimicrobial adjuvants.
Chan WY; Hickey EE; Page SW; Trott DJ; Hill PB
J Vet Pharmacol Ther; 2019 Nov; 42(6):682-692. PubMed ID: 31503362
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of thyme oil, oregano oil, thymol and carvacrol against sensitive and resistant microbial isolates from dogs with otitis externa.
Sim JXF; Khazandi M; Chan WY; Trott DJ; Deo P
Vet Dermatol; 2019 Dec; 30(6):524-e159. PubMed ID: 31566822
[TBL] [Abstract][Full Text] [Related]
18. Update on antimicrobial susceptibilities of bacterial isolates from canine and feline otitis externa.
Hariharan H; Coles M; Poole D; Lund L; Page R
Can Vet J; 2006 Mar; 47(3):253-5. PubMed ID: 16604982
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs.
Park Y; Oh J; Park S; Sum S; Song W; Chae J; Park H
BMC Vet Res; 2020 Apr; 16(1):111. PubMed ID: 32293442
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and mechanisms of resistance to fluoroquinolones in Pseudomonas aeruginosa and Escherichia coli isolates recovered from dogs suffering from otitis in Greece.
Vingopoulou EI; Delis GA; Batzias GC; Kaltsogianni F; Koutinas A; Kristo I; Pournaras S; Saridomichelakis MN; Siarkou VI
Vet Microbiol; 2018 Jan; 213():102-107. PubMed ID: 29291992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
